Navigation Links
Rutgers center sparks 'liquid bandage,' a new frontline wound treatment
Date:2/7/2008

NEW BRUNSWICK, N.J. The Center for Military Biomaterials Research (CeMBR), part of the New Jersey Center for Biomaterials at Rutgers University, has enabled the development of a breakthrough spray-on dressing for injuries. The trademarked GelSpray Liquid Bandage by BioCure Inc., a medical device company in Norcross, Ga., received clearance for marketing from the U.S. Food and Drug Administration (FDA) Feb. 1.

The GelSpray Liquid Bandage is a major advance in the management and care of combat casualty and civilian wounds. Much like epoxy is dispensed in household kits, the dressing is applied with a dual syringe that releases two polymer ingredients. These polymers react rapidly upon mixing to form a gel-based dressing that frontline combat soldiers can apply to their own wounds. The dressing conforms to the wound geometry, adheres to intact skin but not directly to the injured tissue, and resists abrasion.

While created for the military, the GelSpray technology has potential uses in civilian health care. Future versions of the liquid bandage may be suitable for use by civilian rescue teams to treat traumatic wounds and burns, as well as in the treatment of diabetic ulcers, ostomies and post-op wounds. Future products based on the GelSpray technology platform will include active ingredients to treat infection and pain, and control severe bleeding.

Rutgers Center for Military Biomaterials Research was created to link academia, industry and the military to fulfill urgent military medical care needs. Its mission is to familiarize the biomedical research community with the unique needs of combat casualty care and to foster the development of innovative medical technologies to treat injured soldiers. The center is supported with funding from the U.S. Army Medical Research and Materiel Command (USAMRMC) and its Telemedicine and Advanced Technologies Research Center at Fort Detrick, Md.

In this case, it was the mission of our cente
'/>"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
2. Rutgers biomaterial debuts in clinical trials of new stent
3. N.J. nurses are overworked according to Rutgers College of Nursing professor
4. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
5. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
6. Scientists Spot Brains Free Will Center
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
9. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
10. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
11. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...hey received $7.5 million pursuant to the joint ve...nc. to commercialize and develop Zevalin(R) in the...the initial $7.5 million payment in connection wit...y earn up to an additional $15 million in product ...
(Date:1/7/2009)...toward containing health care costs could have the...uctivity, impairing quality and perhaps even incre...ter physicians suggest in a New England Journal o...havioral economics and psychology, Pamela Hartzban...t assigning a monetary value to every aspect of a ...
(Date:1/7/2009)...Jan, 7 Natural Alternatives International, Inc. (...nufacturer and marketer of customized nutritional ...er 31, 2008 its former President, Randell Weaver,s...d it completed certain amendments to its credit fa... the amendments extend the maturity date for the w...
(Date:1/7/2009)...n. 7 WellPoint, Inc. (NYSE: WLP ) announced,tod...at the 27th Annual J.P.,Morgan Healthcare Conferen...,Time (12:30 p.m. Eastern Standard Time). , We...ults for the three,months ended Dec. 31, 2008, on ...a quiet period prior to this scheduled earnings re...
Breaking Medicine News(10 mins):Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 2Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 3Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 4Health News:Cost containment focus could have consequences for health care delivery 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:WellPoint Announces Appearance at Upcoming Conference 2
...w survey by Cancer Research UK says that obese peo...cancer and think they must slim down// only to loo...found that 40% thought looking good was the main r...ile 32% were aware that it lessened cancer risk. "...
... Ridge: The United States Department of Agricultur...he Special Supplemental Nutrition Program// for Wo.... The USDA's proposal will look at reducing the qu...of the food packages. The proposal has indicated t...
...ean-Congo Haemorrhagic Fever (CCHF) has killed at ... of it ever reported since it was identified// in ...s more cases of the Ebola-like disease are bound ... of this disease were reported. .Six provinces in ...
...w screening system combining digital photography w...tive method to screen for a common childhood oral ...er city toddlers. Early childhood dental caries...ottle tooth decay, results from prolonged exposure...
Other Medicine News:Health News:Proposal to revamp WIC food package 2Health News:Crimean-Congo Hemorrhagic Fever hits Turkey 2Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 2Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 3
(Date:1/6/2009)...RNewswire/ -- Pacira Pharmaceuticals, Inc., an,ac...ed today that enrollment,has been completed in tw...,safety and efficacy of a single intraoperative ad... prolonged postoperative analgesia. , Resul...al knee,arthroplasty (TKA) are expected to provid...
(Date:1/3/2009)...EMONT, Ill., Jan. 2 Mag...ogy providing an increasing number of clinical ben...ording to an article in the January 2009 issue of ... Surgeons ( http://www.jaaos.org/ ). It is predic...echnical developments will allow MRI to provide ev...
(Date:12/27/2008)...ar silence, offers to ease cloning costs for Clona...Dec. 27 Six years to th...d child, Dr. Brigitte Boisselier, head of the comp...ther babies cloned by her company are growing up h... families, privacy. , , "We,ve helped almost 10...
(Date:12/17/2008)...FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN ) ...llment in a,Phase 1-2 dose-escalation clinical tr...onist, in castration-resistant prostate cancer pat...S. Food and Drug Administration (FDA) to,advance ... open-label, U.S. Phase 1-2 study evaluated prosta...
Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3'We're Ready to Prove It!' 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 1Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 2DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 1DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 2InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 1InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 2InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 3Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 1Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 2
...., May 09, 2007 /PRNewswire-FirstCall/ --,Catalyst...itive,initial, top-line results from a bioequivale...igabatrin Tablets) is bioavailable and,bioequivale...rketed,in Europe by Sanofi Aventis. These data pot...e extensive body of published pre-clinical,and cli...
...if.--(BUSINESS WIRE)--May 10, 2007 - According to,...65 percent of,female respondents seeking treatment...Painkillers such as Vicodin, OxyContin, Percocet,a...n, 35 percent of,the mothers who reported a depend... to Clare Waismann, registered addiction,specialis...
Other Medicine Technology:Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 2Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 3Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 4Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2
Pneumatic impactor, general surgery, available in various hose connector styles.
The SmartDriver System consists of a pistol-grip handpiece available in Pneumatic, Electric and Battery Power, with a wide range of couplers that can be used in a variety of orthopedic surgical appli
Introducing the new large power line from MicroAire. Our new handpieces function as both cordless AND electric instruments, offering the ultimate in flexibility. Its the versatility the industry has
The 7600 Oscillating Saw offers unparalleled power for large bone osteotomies, thanks to its 14.4V NiMH Rechargeable Battery Pack. The cutting head may be rotated into 12 positions for cutting in any
Medicine Products: